Availability of Nasal Spray Flu Vaccine for At-Home Use in the United States
A new at-home nasal spray flu vaccine, FluMist, is now available in select states, offering a convenient way to receive the annual flu shot without visiting a healthcare facility. Approved for self-administration, this innovation aims to boost vaccination rates and improve public health during flu season.
For the first time, individuals can receive their annual flu vaccination from the comfort of their own homes thanks to the new at-home nasal spray flu vaccine. The product, FluMist, developed by AstraZeneca, has received expanded approval from the U.S. Food and Drug Administration (FDA) to be self-administered, making the vaccination process more convenient and accessible.
FluMist is a nasal spray designed to protect against influenza and has been available in clinics and pharmacies since its initial approval in 2003. The recent FDA approval allows consumers to order the vaccine directly online through a service called FluMist Home, which distributes the nasal spray to homes in 34 states during the 2025–2026 flu season. The vaccine is suitable for individuals aged 2 to 49, with caregivers recommended to administer it to children aged 2 to 17.
To utilize the service, customers must provide personal details, including medical history, insurance information, and payment. The cost of the vaccine is generally covered by most commercial insurance plans, with a shipping and processing fee of $8.99.
It is important to note that the vaccine should not be used by people with severe allergies to its ingredients, eggs, or other flu vaccines. Full safety instructions and product details are available on the official website.
The rollout is currently limited to specific states, including Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Massachusetts, Maryland, Maine, Michigan, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, Nevada, Ohio, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, and Wyoming. Local pharmacy laws may restrict availability in certain regions.
This development marks a significant step forward in vaccine accessibility, especially for individuals who prefer the convenience of home delivery. For more details on how FluMist works, visit the official product site.
Source: https://medicalxpress.com/news/2025-08-nasal-spray-flu-vaccine-home.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Early Immune Challenges and Their Impact on Oral and Systemic Health
Early immune challenges such as HIV exposure can disrupt the oral microbiome's stability, impacting both dental and systemic health in children. Discover key insights from recent research highlighting the importance of early immune system health.
Hotel2Hospital: Transforming Hotels into Emergency Care Facilities for Crisis Response
Discover how the Hotel2Hospital project is revolutionizing emergency preparedness by converting hotels into rapid-response medical facilities to handle patient surges during crises.
New Cellular Mechanism Discovered That Could Lead to Innovative Parkinson's Disease Treatments
A new cellular mechanism has been discovered that could lead to innovative therapies for Parkinson's disease by enhancing mitophagy, the cell's mitochondrial cleanup process.
New Insights into Vagus Nerve Cells as Shields Against Influenza-Induced Lung Damage
New research uncovers the protective role of vagus nerve cells in reducing lung inflammation during influenza infections, opening new avenues for immune-modulating therapies.